» Articles » PMID: 11580924

Serum Platelet-activating Factor Acetylhydrolase (PAF-AH) Activity in More Than 3000 Healthy Japanese

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2001 Oct 3
PMID 11580924
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A spectrophotometric assay for platelet-activating factor acetylhydrolase (PAF-AH) activity differs from the radioisotopic assay in its value because of a difference in substrate specificity. The spectrophotometric assay is more precise than the radioisotopic assay, providing information that is not clear with the radioisotopic assay.

Methods: We measured the serum PAF-AH activity in 3106 healthy Japanese, utilizing the spectrophotometric assay with an Hitachi 7170 automatic analyzer. We also measured the serum PAF-AH activity in 18 healthy volunteers to investigate the effect of diet and the change in activity in a day and over 6 weeks. Changes were examined at 0 (day 1), 1, 2, 4 and 6 weeks.

Results: The mean value for females was significantly lower than that of males at the 5% level and both male and female activity had a tendency to increase with advancing age. It is known that the PAF-AH is primarily associated with LDL in blood and the PAF-AH activity correlated with the total cholesterol (r=0.52, n=126) and the LDL cholesterol (r=0.60, n=126) concentrations. In the diet study, there was no observable effect on activity. No difference in PAF-AH activity was observed between serum and plasma sample types. The serum PAF-AH activity was stable at 7 degrees C for at least 7 days and at -20 degrees C for at least 2 months.

Conclusions: The serum PAF-AH activity in women was lower than in men until the menopausal age was reached. We could use not only fresh fasting serum, but also plasma sample, non-fasting sample and stored sample to estimate the PAF-AH activity.

Citing Articles

Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum.

Feng L, Feng G, Chen Y Lipids Health Dis. 2014; 13:6.

PMID: 24393260 PMC: 3895822. DOI: 10.1186/1476-511X-13-6.


Determination of phospholipase activity of PAF acetylhydrolase.

Stafforini D, McIntyre T Free Radic Biol Med. 2012; 59:100-7.

PMID: 22659315 PMC: 3444653. DOI: 10.1016/j.freeradbiomed.2012.05.031.


Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.

Chalbot S, Zetterberg H, Blennow K, Fladby T, Grundke-Iqbal I, Iqbal K Clin Chem. 2009; 55(12):2171-9.

PMID: 19850632 PMC: 2857971. DOI: 10.1373/clinchem.2009.130286.


Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?.

Khuseyinova N, Koenig W Mol Diagn Ther. 2007; 11(4):203-17.

PMID: 17705575 DOI: 10.1007/BF03256242.


Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.

Serban M, Tanaseanu C, Kosaka T, Vidulescu C, Stoian I, Marta D J Cell Mol Med. 2003; 6(4):643-7.

PMID: 12611648 PMC: 6741328. DOI: 10.1111/j.1582-4934.2002.tb00462.x.